CTIS2023-503749-76-00进行中（未招募）1 期
BP41628
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 171
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe AsthmaModerate to Severe AsthmaMedDRA version: 20.0Level: PTClassification code: 10003553Term: Asthma Class: 100000004855CTIS2023-504304-29-00F. Hoffmann-La Roche AG90
招募中
1 期
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART)CTIS2023-507630-25-00Ferring Pharmaceuticals A/S600
进行中（未招募）
1 期
A study in healthy men to test how BI 764198 is processed in the bodyHealthyMedDRA version: 21.0Level: LLTClassification code: 10053349Term: Pharmacokinetic study Class: 10022891CTIS2022-502327-22-00Boehringer Ingelheim International GmbH16
招募中
1 期
A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple dosesInflammatory Gastrointestinal DiseaseMedDRA version: 20.0Level: HLGTClassification code: 10017969Term: Gastrointestinal inflammatory conditions Class: 10017947CTIS2023-507882-24-00Ferring Pharmaceuticals A/S48
进行中（未招募）
1 期
Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteersMedDRA version: 21.1Level: LLTClassification code: 10045023Term: Tuberculosis prophylaxis Class: 10042613MedDRA version: 21.1Level: PTClassification code: 10072084Term: Tuberculosis immunisation Class: 100000004865TuberculosisCTIS2023-509515-89-00BioNTech SE128